83 FR 30448 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 125 (June 28, 2018)

Page Range		30448-30448
FR Document		2018-13894

Federal Register, Volume 83 Issue 125 (Thursday, June 28, 2018)

[Federal Register Volume 83, Number 125 (Thursday, June 28, 2018)]
[Notices]
[Page 30448]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-13894]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Developmental Therapeutics.
    Date: July 9, 2018.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Sharon K. Gubanich, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6195D, MSC 7804, Bethesda, MD 
20892, (301) 408-9512, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 22, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-13894 Filed 6-27-18; 8:45 am]
 BILLING CODE 4140-01-P

30448 Federal Register / Vol. 83, No. 125 / Thursday, June 28, 2018 / Notices

State Enforcement Notifications jurisdiction. However, before doing so, action precludes State action under the
a State must provide notice to FDA FD&C Act.
OMB Control Number 0910–0275—
according to § 100.2 (21 CFR 100.2). The In the Federal Register of February 7,
Extension
information required in a letter of 2018 (83 FR 5438), FDA published a 60-
This information collection supports notification under § 100.2(d) enables us day notice requesting public comment
Agency regulations. Specifically, section to identify the food against which a on the proposed collection of
310(b) of the Federal Food, Drug, and State intends to take action and to information. FDA received one
Cosmetic Act (FD&C Act) (21 U.S.C. advise that State whether Federal comment in support of the information
337(b)) authorizes a State to enforce enforcement action against the food has collection.
certain sections of the FD&C Act in its been taken or is in process. With certain FDA estimates the burden of this
own name and within its own narrow exceptions, Federal enforcement collection of information as follows:

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of Average
Number of Total annual
21 CFR part responses per burden per Total hours
respondents responses
respondents response

21 CFR Section 100.2(d) ..................................................... 1 1 1 10 10
1 There are no capital costs or operating and maintenance costs associated with this collection of information.

The estimated burden for this confidential trade secrets or commercial DEPARTMENT OF HEALTH AND
information collection has not changed property such as patentable material, HUMAN SERVICES
since the last OMB approval. The and personal information concerning
estimated reporting burden for individuals associated with the grant National Institutes of Health
§ 100.2(d) is minimal because applications, the disclosure of which
enforcement notifications are seldom Prospective Grant of an Exclusive
would constitute a clearly unwarranted
used by States. During the last 3 years, Patent License: Development of an
invasion of personal privacy.
we have not received any new Anti-Mesothelin Chimeric Antigen
enforcement notifications; therefore, we Name of Committee: Center for Scientific Receptor (CAR) for the Treatment of
estimate that one or fewer notifications Review Special Emphasis Panel; Human Cancer
Developmental Therapeutics.
will be submitted annually. Although
we have not received any new Date: July 9, 2018. AGENCY: National Institutes of Health,
Time: 12:00 p.m. to 3:00 p.m. Department of Health and Human
enforcement notifications in the last 3
Agenda: To review and evaluate grant Services.
years, we believe these information
applications.
collection provisions should be ACTION: Notice.
Place: National Institutes of Health, 6701
extended to provide for the potential
Rockledge Drive, Bethesda, MD 20892
future need of a State government to (Telephone Conference Call). SUMMARY: The National Cancer Institute,
submit enforcement notifications Contact Person: Sharon K. Gubanich, an institute of the National Institutes of
informing us when it intends to take Ph.D., Scientific Review Officer, Center for Health, Department of Health and
enforcement action under the FD&C Act Scientific Review, National Institutes of Human Services, is contemplating the
against a particular food located in the Health, 6701 Rockledge Drive, Room 6195D, grant of an Exclusive Patent License to
State. MSC 7804, Bethesda, MD 20892, (301) 408– practice the inventions embodied in the
Dated: June 21, 2018. 9512, gubanics@csr.nih.gov. U.S. Patents and Patent Applications
Leslie Kux, This notice is being published less than 15 listed in the Supplementary Information
Associate Commissioner for Policy. days prior to the meeting due to the timing section of this notice to Atara
[FR Doc. 2018–13868 Filed 6–27–18; 8:45 am] limitations imposed by the review and Biotherapeutics Inc. (‘‘Atara’’) located in
funding cycle. South San Francisco, CA.
BILLING CODE 4164–01–P
(Catalogue of Federal Domestic Assistance DATES: Only written comments and/or
Program Nos. 93.306, Comparative Medicine; applications for a license which are
DEPARTMENT OF HEALTH AND 93.333, Clinical Research, 93.306, 93.333, received by the National Cancer
HUMAN SERVICES 93.337, 93.393–93.396, 93.837–93.844, Institute’s Technology Transfer Center
93.846–93.878, 93.892, 93.893, National on or before July 13, 2018 will be
National Institutes of Health Institutes of Health, HHS) considered.
Center for Scientific Review; Notice of Dated: June 22, 2018.
ADDRESSES: Requests for copies of the
Closed Meeting Sylvia L. Neal, patent application, inquiries, and
Program Analyst, Office of Federal Advisory comments relating to the contemplated
Pursuant to section 10(d) of the Committee Policy.
Federal Advisory Committee Act, as an Exclusive Patent License should be
amended, notice is hereby given of the
[FR Doc. 2018–13894 Filed 6–27–18; 8:45 am] directed to: Rose M. Freel, Ph.D.,
amozie on DSK3GDR082PROD with NOTICES1

following meeting. BILLING CODE 4140–01–P Licensing and Patenting Manager, NCI
Technology Transfer Center, 8490
The meeting will be closed to the
Progress Drive, Suite 400, Frederick, MD
public in accordance with the
21701; Telephone: (301)–624–8775;
provisions set forth in sections
Facsimile: (240)–276–5504; Email:
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
rose.freel@nih.gov.
as amended. The grant applications and
the discussions could disclose SUPPLEMENTARY INFORMATION:

VerDate Sep<11>2014 17:08 Jun 27, 2018 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\28JNN1.SGM 28JNN1

Document Created: 2018-11-06 09:55:27
Document Modified: 2018-11-06 09:55:27

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 9, 2018.
FR Citation		83 FR 30448

83 FR 30448 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 125 (June 28, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health